Literature DB >> 8285595

Oligodendrocytes in the early course of multiple sclerosis.

W Brück1, M Schmied, G Suchanek, Y Brück, H Breitschopf, S Poser, S Piddlesden, H Lassmann.   

Abstract

The neuropathology of demyelinating lesions in multiple sclerosis was studied in specimens obtained by diagnostic needle biopsy during early stages of the disease. The lesions were characterized by a chronic inflammatory reaction dominated by lymphocytes and macrophages, plaque-like demyelination, and astroglial sclerosis. Oligodendrocytes within the lesions were studied by immunocytochemistry using antibodies against various myelin and oligodendroglia components. The expression of messenger RNA for proteolipid protein was determined by in situ hybridization. Our studies revealed that myelin-oligodendrocyte glycoprotein is a sensitive and reliable marker for identification of oligodendrocytes in demyelinated plaques. The results suggest that in the early course of the disease in some patients, oligodendrocytes may largely be preserved, whereas in others oligodendroglial loss is pronounced. Loss of oligodendrocytes was only marginally related to the stage of demyelinating activity within the lesions. These findings indicate that the pathogenesis of demyelination may vary within different multiple sclerosis patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8285595     DOI: 10.1002/ana.410350111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

Review 1.  Early-stage multiple sclerosis : what are the treatment options?

Authors:  Per Soelberg Sorensen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis.

Authors:  A Campi; M Filippi; G Comi; G Scotti; S Gerevini; V Dousset
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells.

Authors:  G Wolswijk
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

Review 5.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 6.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; S Sathornsumetee; M Rodriguez
Journal:  Brain       Date:  2001-07       Impact factor: 13.501

Review 8.  Clinical implications of neuropathological findings in multiple sclerosis.

Authors:  Wolfgang Brück
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

9.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.

Authors:  L Claudio; C S Raine; C F Brosnan
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.